The project will publish an open-access techno-economic analysis (TEA) investigating a two-stage byproducts-to-lipids production system and modeling production choice trade-offs. The wet lab work will analyze organism lipid profiles under various growth conditions to inform the TEA.
The project aims to develop a sustainable toolbox of edible fungi strains to obtain intact RuBisCO from green tea. It bridges fungi fermentation with leaf protein production from waste streams, generating two promising alternative proteins in a single system.
Poor and inauthentic flavors of current seafood alternatives are a barrier to consumers’ acceptance. To address this shortcoming, the precision fermentation startup Nectariss plans to develop realistic seafood flavors based on the fermentation of mycelial fungi.
Dr. Speranza’s project explores solid-state fermentation to develop a protein ingredient with enhanced functionality and nutrition from peanut meal, an underutilized, high-volume by-product. The ingredient will be used to produce meat analogues with a desirable fibrous texture.
This project will optimize large-scale fermenter design and operating conditions. The team will model cell growth, fluid dynamics, and cell viability during scale up. Simultaneously, they will use flow chambers to understand cells’ reaction to physical and chemical stresses.
The Brodsky-Hanga collaboration will define an intracellular pathway in porcine muscle responsible for the uptake of glucose. The goal is to exploit this understanding to nourish cultured muscle cells for cultivated meat production.
This project will incorporate computational fluid dynamics and genome-scale metabolic models into techno-economic analyses. This detailed model of bioreactor performance and cell behavior will enable assessment and optimization of novel bioreactor designs more cost effectively than building and testing prototypes.
This project aims to identify affordable plant albumins for culture media. Dr. Richards and his team will characterize at least six plant albumins that support fish cell growth.
Dr. Minic and his team will screen algal strains to produce extracts for cell media, focusing on albumin replacements. This project will produce inexpensive algal extracts with high potency to replace albumin in fetal bovine serum, significantly lowering media cost.
This project will develop novel edible and bioactive microcarriers for scalable, efficient, and reproducible cultivated fish production. These microcarriers will allow in vitro cultivation of fish embryonic stem cells and controlled delivery of essential molecules for cell growth.
